MBL Wealth
RVMD icon

MBL Wealth’s Revolution Medicines RVMD Stock Holding History

MBL Wealth’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$356K Buy
+1,734
New +$344K 0.02% 412

Other funds holding RVMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Alphabet Inc
Alphabet Inc Mountain View, California $88.3B AUM 46.07% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return

MBL Wealth's RVMD Position: Q3 2026 in Review

MBL Wealth opened a new position in Revolution Medicines (RVMD) in Q3 2026: 1,734 shares worth $356K. The stake represents 0.02% of the portfolio and ranks #412 among its holdings.

530 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • MBL Wealth held 1,734 shares of Revolution Medicines worth $356K as of Q3 2026.
  • Revolution Medicines was a new MBL Wealth position in Q3 2026.
  • Revolution Medicines made up 0.02% of MBL Wealth's portfolio in Q3 2026, its #412 holding.
  • 530 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on MBL Wealth's 13F filing for Q3 2026, filed 22 Oct 2026.